Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme

Pharmacology 0303 health sciences Science & Technology MUTATIONS SIGNATURE TEMOZOLOMIDE BIOLOGY RM1-950 ferroptosis 3. Good health glioblastoma multiforme 03 medical and health sciences multi-omics analysis CELLS SURVIVAL IDH1 Pharmacology & Pharmacy SENSITIZES GLIOBLASTOMA prognosis Therapeutics. Pharmacology 1115 Pharmacology and Pharmaceutical Sciences Life Sciences & Biomedicine PACKAGE
DOI: 10.3389/fphar.2022.898679 Publication Date: 2022-04-28T04:46:36Z
ABSTRACT
Glioblastoma multiforme (GBM) is the most common type of malignant brain tumor, among which IDH1-wild GBM has a poor prognosis. Recent studies have shown that ferroptosis-related genes (FRGs) are correlated with development and progression cancer. In GBM, role FRGs associated IDH1 status as biological indicators therapeutic targets remains to be clarified. Ten (STEAP3, HSPB1, MAP1LC3A, SOCS1, LOX, CAPG, CP, GDF15, CDKN1A, CD44) in were identified key through screening by survival analysis Random Forest using The Cancer Genome Atlas (TCGA) datasets, protein expressions verified. Transwell qPCR results showed ferroptosis promoted migration glioblastoma cells affected expression genes. Our study established prognostic model for patients based on ten different modeling method from previous study, GSVA algorithm. Further, we took methods functional enrichment analysis, clinical characteristics, immune cell infiltration, immunomodulator, ESTIMATE single nucleotide variant (SNV) molecular mechanisms strongly immune-related factors significantly involved p53 signaling pathway, senescence autophagy cancer, negative regulation kinase activity. Moreover, potential drugs Virtual Screening Molecular Docking. indicated novel ferrotosis-related possessed values.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (8)